PHARMACOLOGICAL STUDY |
|
Year : 2015 | Volume
: 36
| Issue : 3 | Page : 335-340 |
|
Antihyperglycemic activity of Albizzia lebbeck bark extract in streptozotocin-nicotinamide induced type II diabetes mellitus rats
Priyank A Patel, Mihir P Parikh, Sarika Johari, Tejal R Gandhi
Department of Pharmacology, Anand Pharmacy College, Anand, Gujarat, India
Correspondence Address:
Mihir P Parikh Asst. Prof., Department of Pharmacology, Anand Pharmacy College, Anand - 388 001, Gujarat India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-8520.182752
|
|
Introduction: Albizzia lebbeck (L.) Benth. (Family - Leguminosae) extract is a proven mast cell stabilizing agent. Mast cells are involved in the inflammatory processes leading to the diabetes mellitus. Aim: To evaluate the effect of A. lebbeck against experimentally induced type 2 diabetes mellitus in rats. Materials and Method: Female Sprague-Dawley rats were randomly allocated to six groups (n = 6). Diabetes was induced by single intraperitoneal injection of streptozotocin (50 mg/kg) given after 15 min of nicotinamide administration (110 mg/kg). Treatment with methanolic extract of A. lebbeck bark (MEAL) and metformin drug as standard was given for 21 days. Serum glucose (GLU) levels were measured on the 0 day and on 1st, 7th, 14th and 21st day after diabetes induction. After completion of study period, various biochemical parameters in serum such as - GLU, lipid profile, urea and creatinine were estimated. One-way analysis of variance followed with post-hoc Dunnett's test was used to analyse the data. Statistical significance for the values was set at P< 0.05. Results: MEAL significantly decreased the level of serum GLU, creatinine, urea, cholesterol, triglycerides, low-density lipoprotein-cholesterol, very low-density lipoprotein-cholesterol and increased high-density lipoprotein levels. Conclusion: A. lebbeck bark extract showed antihyperglycaemic activity along with antihyperlipidemic effect. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|